Oral Bioavailability Predictions for Selected Compounds via SwissADME

5.5 KB of tabular data contains oral bioavailability predictions for selected compounds based on Veber and Egan rules, as calculated by the SwissADME server. The dataset was authored by Courage Siame and uploaded to figshare, with a last update timestamp of 2026-05-06. It is available under a CC-BY-4.0 license.

Use Cases

• Filtering candidate compounds for drug development based on predicted oral bioavailability.
• Benchmarking the Veber and Egan rules for bioavailability prediction.
• Validating or comparing results from the SwissADME prediction server.
• Training or testing machine learning models for ADME property estimation.

Strengths

• Dataset is openly licensed under CC-BY-4.0.
• File size is 5.5 KB, indicating a focused and manageable scope.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare

Collection Method

Predictions generated by the SwissADME server.

Freshness

Last updated 2026-05-06 17:26:47; freshness should be verified.